Shareholder Nominated Directors


更新时间:2004/03/20 阅读次数:214

First, Hanover Compressor settled a shareholder lawsuit, agreeing to allow shareholders to nominate two independent directors. More recently, Pensions&Investments (1/12/04) reported that HealthSouth agreed to a settlement with the Louisiana Teachers' Retirement System. The fund will name eight nominees to the HealthSouth board including the following luminaries:
  • Richard H. Koppes, formerly with CalPERS, currently Jones Day Reavis & Pogue, with projects too numerous to list;
  • Charles M. Elson, law professor at the University of Delaware, Newark, and director of its Weinberg Center for Corporate Governance;
  • John C. Coffee Jr., professor and director of Center on Corporate Governance at Columbia University Law School, New York; and
  • Margaret M. Foran, vice president-corporate governance and secretary at Pfizer Inc., New York.

In addition, the Louisiana fund created a mechanism to gather more nominees from other institutional investors.

The SEC is currently in the process of developing a relatively toothless plan that would give shareholders the right to nominate board candidates under extremely limited circumstances. If the regulations are enacted as proposed, we may see more changes through shareholder lawsuits than through the new rules.

Now HealthSouth is back in the news after identifying $2.5 billion in fraudulent accounting entries and millions more in aggressive maneuvers, adding up to between $3.8 billion and $4.6 billion in bookkeeping irregularities. They hope to hire a new management team by June 2004 and to release restated financial statements by the first quarter of 2005. The company's former chief executive, Richard M. Scrushy, is scheduled to go to trial on 85 counts of fraud and money laundering this summer. How much shareholder value has been lost that could have been avoided if any significant shareholder could have placed director nominees on the corporate proxy?

CBS.MarketWatch.com (1/21/04) reports the SEC is planning a forum on the proposal for late February or early March. It's unclear when the commission will formally consider the proposal. Staff is reportedly still going through more than 12,000 comments, the vast majority of which called for shareholder access to the corporate proxy for their director nominees. Let’s keep the pressure on.